The mechanism(s) of c-Myc transcription factor-induced apoptosis is still obscure. The activation of c-Myc has been found to lead into the processing/activation of caspases (caspase-3), but the signi®cance of this for the cell demise is debatable. Here we report that several targets of caspases (PKCd, MDM2, PARP, replication factor C, 70 kDa U1snRNP, fodrin and lamins) are cleaved during c-Myc-induced apoptosis in Rat-1 MycER TM cells, indicating an important role for caspases in the apoptotic process. We further found that the ATM (ataxia telangiectasia mutated) ± protein is a novel key substrate of caspases. In in vitro assays, puri®ed recombinant ATM protein was found to be cleaved by the eector caspases 3 and 7. The functional signi®cance of the ATM cleavage is supported by the ®nding that ectopic expression of ATM protected in part against apoptosis. We also show that c-Myc-induced apoptosis involves loss of mitochondrial transmembrane potential, release of cytochrome c from mitochondria into the cytosol and subsequent processing of caspase-9. The cleavage of caspase-9 is, however, minimal and a much later event than the processing/activation of caspase-3, suggesting that it is not the apical caspase. Evidence is provided that there is, nevertheless, an upstream caspase(s) regulating the functions of caspase-3 and mitochondria. Additionally, it was found that p53 becomes upregulated, together with its transcriptional targets MDM2 and p21, upon c-Myc induction, but this occurs also at a later time than the activation of caspase-3.
Introduction c-Myc is a helix ± loop ± helix transcription factor associated with cell growth and dierentiation, but also with programmed cell death, apoptosis. The molecular mechanisms of apoptosis induced by c-Myc are still poorly understood if compared, for example, to the various death receptor-mediated forms of apoptosis. One major enigma is how c-Myc, a nuclear protein, initiates apoptosis involving cytoplasmic events. The transactivation domain of c-Myc is essential for all identi®ed functions of c-Myc, which implies that also apoptosis induced by c-Myc may be achieved by transcription of the target genes (Galaktionov et al., 1996; Packham and Cleveland, 1994; Shim et al., 1997) . On the other hand, c-Myc has been reported to induce apoptosis without transcriptional activation (Evan et al., 1992; Xiao et al., 1998) . Also, it is not clear whether the tumour suppressor p53, a transcriptional target for cMyc, is needed for apoptosis induced by c-Myc (Lotem and Sachs, 1995; Shim et al., 1998; Wagner et al., 1994; Zindy et al., 1998; reviewed in Prendergast, 1999; Thompson, 1998) . Recently, c-Myc-induced apoptosis has been shown either indirectly (Kagaya et al., 1997; McCarthy et al., 1997) or directly (Kangas et al., 1998) to be associated with the activation of caspases, members of the CED3/ICE-family of cysteine proteases. However, it has also been suggested that caspases would not be critically involved in the execution of the apoptotic cell death induced by c-Myc (McCarthy et al., 1997; Tsunoda et al., 1999, reviewed in Green and Kroemer, 1998) . Further, data demonstrating a requirement for the CD95 receptor-ligand pathway (known to involve the caspase and/or Jun N-terminal kinase pathways) in c-Myc-induced apoptosis has been obtained (Hueber et al., 1997) .
In this study, our aim was to assess the role of caspases in c-Myc-induced apoptosis by analysing a variety of essential proteins documented to become cleaved by caspases in other apoptotic systems. We also searched for novel key substrates for caspases by studying known pivotal proteins with potential caspase cleavage sites. One such putative target protein identi®ed is the ATM (ataxia telangiectasia mutated) protein, which is homologous to DNA-dependent protein kinase (DNA ± PK), a known substrate of caspases (CasciolaRosen et al., 1996; Song et al., 1996) . ATM is responsible for the ataxia telangiectasia (AT) -disease, the clinical features of which are numerous including dilated blood vessels, cerebellar degeneration, defects of immune system, chromosomal aberrations and predisposition to cancer (for a review see Morgan and . The AT-cells are extremely sensitive to radiation. They fail to arrest in the cell cycle (in G1, S, and G2) after ionising radiation-induced DNA damage (reviewed in Meyn, 1995) and proceed in the cycle but eventually die at G2, presumably by apoptosis. The AT-cells display an altered expression of p53 protein (Canman et al., 1994; Kastan et al., 1992) , and also the expression of the p53 target genes (p21, gadd45, mdm2) is altered (Canman et al., 1994; Kastan et al., 1992) . The ATM protein has a region homologous to the protein kinase domain of the phosphatidylinositol-3-kinase protein (Savitsky et al., 1995) and possesses kinase activity. ATM can associate with and phosphorylate the product of c-abl proto-oncogene (Baskaran et al., 1997; Shafman et al., 1997) suggested to play a role in the regulation of G1/S transition. Moreover, ATM has been shown recently to phosphorylate p53 on Ser15 after DNA damage (Banin et al., 1998; Canman et al., 1998) , which may be of importance for the p53-mediated cell cycle arrest and apoptosis.
Further, possible mitochondrial alterations (loss of mitochondrial transmembrane potential, release of cytochrome c), and accumulation of p53 protein, and their kinetic relationships with the activation of caspases were analysed.
Results

Cleavage of previously known substrates of caspases during c-Myc-induced apoptosis
To assess the functional role of caspases in c-Mycinduced apoptosis, we studied the fate of potential caspase targets in the ®broblastic Rat-1 MycER TM cell line expressing a chimeric c-Myc/oestrogen receptor protein, activated by 4-hydroxytamoxifen (OHT) (Evan et al., 1992; Littlewood et al., 1995) . The Rat-1 MycER TM cells were starved for 24 h in 0.5% FCS, whereafter 100 nM OHT was added to induce apoptosis. As depicted in Figure 1a ,b, many proteins identi®ed previously as targets of caspases are the victims also in c-Myc-induced apoptosis in rat ®broblasts. The target proteins can be divided roughly into three subgroups by their function in cells. First, PKCd and MDM2 (shown in Figure 8 ) are regulatory proteins involved in signal transduction and cell cycle progression. Second, poly(ADP-ribose) polymerase (PARP), replication factor C (RFC), and the 70 kDa subunit of U1 snRNP are involved in the maintenance of the integrity of the genome and replication of DNA, and in the processing of the mRNA transcripts, respectively. Third, fodrin/BIIspectrin together with lamins A, B1 and B2 are structural (cytoskeletal and nuclear) proteins, which get proteolytically processed. Most of the proteins studied above are beginning to be cleaved relatively early (by 24 h) after the induction of c-Myc expression in relation, for example, to the degradation of DNA occurring later in these cells (Kangas et al., 1998) . That c-Myc is responsible for induction of these caspase-mediated protein cleavages, is evidenced by the fact that treatment of parental, serum-starved Rat-1 cells (without MycER) with OHT did not lead into the activation of caspases and proteolysis (data not shown). These data lend support to the idea that the function of caspases is important for c-Myc-induced apoptosis.
Of the proteins found to become degraded during the cell death induction by c-Myc, many are thought to be substrates for caspase-3 or caspase-7. So far, PKCd is documented to be cleaved only by caspase-3 and not Figure 1 (a,b) Proteolytical processing of known substrates of caspases during c-Myc-induced apoptosis. Rat-1 MycER TM cells, starved in 0.5% FCS for 24 h, were treated with or without OHT (+/7) for the indicated times. Total cell lysates were analysed by Western blotting for the indicated proteins. In (a) panels, the samples are derived from the same lysates and the loading control shows reblotting of the particular ®lter with an anti-actin antibody, and in (b) the loading control represents a non-speci®c, low molecular weight band reacting with the anti-fodrin antibody and stands for all the panels. Asterisk (*) denotes the intact protein and the cleavage products are indicated by arrows. Sizes of molecular weight markers are shown on the left by caspases 1, 2, 4, 5, 6, or 7 in vitro (Ghayur et al., 1996) , and thus it is most likely that caspase-3 is the enzyme responsible for the processing of PKCd in vivo in rat ®broblasts. The lamins again are known to be processed only by caspase-6 (Nicholson and Thornberry, 1997) . Based on these data, it seems that at least two eector caspases, caspase-3 and caspase-6, become activated in c-Myc-induced apoptosis. Additionally, we have also found that the third eector, caspase-7, becomes processed/activated (Hotti et al. manuscript in preparation) .
It may also be noteworthy that actin (Figure 1a) , gelsolin, Rb, cPLA 2 and SREBP (data not shown) were not found to be cleaved after the induction of c-Myc expression. Further, we were unable to detect expression of Gas2 or D4-GDP dissociation inhibitor for the Rho family with the antibodies used.
ATM is proteolytically cleaved during c-Myc-induced apoptosis
In searching for novel important targets of caspases, we investigated whether the ATM protein, which has many potential caspase cleavage sites, could be a target of caspases in c-Myc-induced apoptosis. As shown in Figure 2a , the full-length ATM protein of 350 kDa is degraded relatively early during c-Myc-induced apoptosis to yield at least four cleavage products in rat ®broblasts. Their sizes were estimated to be about 50, 60, 150 and 230 kDa. (A better visualization of the 230 kDa band can be seen in Figure 2e where a 6% SDS ± PAGE gel better separates this fragment from a non-speci®c band nearby). It is noteworthy that the cleavage of ATM is not limited to c-Myc-induced apoptosis, as ATM becomes proteolytically cleaved also in staurosporine treated Rat-1 and HL-60 -cells (Figure 2b ,c) concomitant with the cleavage of PARP upon caspase activation (Figure 2d) .
To assess the dependency of the proteolytic processing of ATM on caspase activation, the expression of c-Myc and apoptosis was induced in the presence of Z-VAD-fmk, a pan-inhibitor of caspases. As shown in Figure 2e , the inhibition of caspase activity by Z-VADfmk prevented the cleavage of the full-length ATM protein and the appearance of the proteolytic fragments, demonstrating that a caspase(s) is directly or indirectly responsible for the proteolytic cleavage of the rat ATM protein. In the human and mouse ATM protein, there are several potential recognition sites for caspase-3, which is activated in Rat-1 MycER TM -cells Rat-1 ®broblasts were incubated without (7) or with (+) 0.5 mM staurosporine for 4 h, whereafter total cell lysates were analysed for the ATM cleavage by immunoblotting. (c) HL-60 cells were treated with (+) or without (7) 1 mM staurosporine for 2 or 6 h and total cell lysates were subjected to Western blot analysis of ATM. (d) The cleavage of PARP in staurosporine treated HL-60 cells is shown to verify the apoptotic status of the cells. (e) Rat-1 MycER TM cells were grown as described in (a) in the presence or absence of the caspase inhibitor Z-VAD (100 mM, 24 h) and total cell lysates were subjected to Western blot analysis of ATM protein following c-Myc induction and apoptosis (Kangas et al., 1998) , as well as for the other caspases. The antibody used to detect the rat ATM protein was generated against the amino acid region 1980 ± 2338 of the human ATM protein. A dierential usage of the possible caspase cleavage sites along the protein could yield several protein fragments that could represent the detected proteolytic products. The exact cleavage sites on the rat ATM protein remain to be determined ± once the rat ATM gene has been cloned ± by using proteins with mutations in the speci®c Asp-sites and by in vitro degradation studies with dierent caspases.
Recombinant human ATM protein is cleaved by caspase-3 and caspase-7
To identify the potential caspase(s) responsible for the cleavage of human ATM, recombinant ATM protein was isolated from 293-EBNA cells transfected with an expression vector carrying a FLAG-tagged, full-length human ATM cDNA (see Materials and methods) and incubated in the presence of equal amounts of various active recombinant caspases. As shown in Figure 3a , the 350 kDa intact ATM protein was cleaved to a fragment of about 230 kDa by caspases 3 and 7 (the latter producing a doublet), while caspases 6 and 8 (that were con®rmed to be active; see Figure 3b ) did not seem to be capable of cleaving ATM at the concentration and incubation time used. As shown above, a fragment of this size is also generated in the apoptotic cells in vivo, suggesting that the caspases 3 and 7, both of which we have found to become activated by Myc in the Rat-1 MycER TM cells, may also contribute to the degradation of ATM in vivo.
Ectopic expression of human ATM protein inhibits c-Myc-induced apoptosis
To study the functional signi®cance of the proteolysis of ATM in c-Myc-induced apoptosis, the Rat-1 MycER TM cells were transfected with the FLAG-tagged wild-type ATM expression vector (pEBS7-YZ5). The empty vector (pEBS7) was used as a control. The transfectants were selected for hygromycin resistance for 3 ± 4 weeks, and the surviving population was tested for the expression of the recombinant ATM and for its eects on c-Myc-induced apoptosis (Figure 4) . Notably, ectopic expression of the ATM protein protected in part from c-Myc-induced apoptosis, indicating that the cleavage of ATM contributes to the cell death induced by c-Myc in these cells.
c-Myc-induced apoptosis is associated with loss of mitochondrial transmembrane potential in a caspase-dependent manner Given that mitochondrial changes may activate caspases or independently induce apoptosis (Green and Reed, 1998 and references therein), the possible involvement of mitochondria in the apoptotic process induced by c-Myc was studied. Rat-1 MycER TM cells were starved for 24 h in 0.5% FCS and then treated with OHT as above to induce apoptosis. The cells were harvested at 12, 24 or 48 h and analysed for the mitochondrial transmembrane potential by exploiting the ability of the mitochondria to incorporate 3,3'-dihexyloxacarbocyanine iodide [DioC 6 (3)]. At 12 h there was no detectable change in the mitochondria yet, but, as shown in Figure 5 , at about 24 h there was a reduction in the level of DioC 6 (3)-incorporation in cells with induced c-Myc expression, indicating a loss of the transmembrane potential.
Treatment of the cells with the broad-spectrum caspase inhibitor Z-VAD-fmk (150 mM) inhibited the loss of the transmembrane potential during the 24 h period ( Figure 5 ). Z-DEVD-fmk (50 mM, see Kangas et al., 1998) , an inhibitor of caspase-3-like proteases, was much less eective (data not shown). This demonstrates that the inhibition of the activity of caspases or other Z-VAD sensitive protease(s) prevents or delays the loss of mitochondrial transmembrane potential suggesting that there is an upstream caspase regulating the mitochondrial changes. Though caspase-3 starts to be cleaved 8 h after the initiation of apoptosis and is further activated at 16 ± 24 h (Kangas et al., 1998) , the inability of Z-DEVD to inhibit the loss of the transmembrane potential at 24 h suggests that a discrete caspase, acting upstream of or parallel with caspase-3, is activated during the early phase of the apoptotic process. The activity of caspase-6 was checked by a speci®c cleavage of lamin A in isolated HeLa cell nuclei incubated in the presence of the recombinant caspases (Orth et al., 1996) . The reaction products were solubilized in Laemmli sample buer and subjected to Western blot analysis with antibodies to lamin A+B2. To verify the caspase-8 activity, the recombinant enzyme was incubated with HeLa cell cytosolic extracts (or recombinant caspase-3), and the samples were then analysed for the cleaved proteins by immunoblotting with antibodies to caspase-3 (or Bid, data not shown)
Release of cytochrome c during c-Myc-induced apoptosis Subsequently, the possible release of mitochondrial proteins was studied. After inducing the c-Myc activity, the Rat-1 MycER TM cells were fractionated into the crude mitochondrial and cytoplasmic fractions, and immunoblotted for the presence of cytochrome c. As shown in Figure 6 , a release of cytochrome c from the mitochondria into the cytoplasm takes place. The translocation can be observed relatively early at about 8 ± 16 h after the induction of c-Myc expression, whereafter it steadily increases and reaches its maximum at 48 h ( Figure 6 and data not shown).
As the cytoplasmic cytochrome c is known to form a complex (called apoptosome) with Apaf-1, ATP, and caspase-9 and thereby promote the autocatalytic proteolytic processing and activation of caspase-9 (Zou et al., 1997) , the eect of the cytochrome c release on caspase-9 was studied in the Rat-1 MycER TM cells. Figure 7a depicts the immunoblotting of caspase-9 during apoptosis induced by c-Myc. Surprisingly, no proteolytic processing of caspase-9 was observed until 48 h, when a minor proteolytic TM cells were transfected with an episomal expression vector carrying a FLAG-tagged, full-length human ATM cDNA and hygromycin resistance marker. As a control, cells were transfected with the empty vector. After selection of stable transfectants, the populations of surviving cells were cultured with or without OHT (+/7) for the indicated times, and apoptosis was scored by counting the number (percentage) of dead, detached cells in a Coulter counter. The results are shown as means (+) standard deviation of three or four independent experiments at both the indicated times. It is notable that, the protective eect of ATM against the c-Myc-induced apoptosis was also found at the other points analysed, i.e. at the earlier (24 ± 30 h) and later (72 h) phases of apoptosis. (b) The stable populations of the transfected cells were subjected to Western blotting analysis of the recombinant ATM protein. Total protein were separated by SDS ± PAGE and blotted with monoclonal anti-FLAG M2 antibody Figure 5 Apoptosis induced by c-Myc is accompanied by a loss of mitochondrial transmembrane potential. To measure mitochondrial transmembrane potential the Rat-1 MycER TM cells were exposed to the mitochondria-speci®c DioC 6 (3)-dye and its incorporation was analysed by FACS. (a) Rat-1 MycER TM cells were starved in 0.5% FCS (24 h) and cultured without 4-hydroxytamoxifen (OHT) (dark grey) or with OHT (light grey), or with both OHT and the caspase-inhibitor Z-VAD for 24 h (white), whereafter the uptake of DioC 6 (3) was determined. (b) Incorporation of DioC 6 (3) into cells grown in 5% FCS (control, with normal membrane potential) (light grey) or into cells treated with the uncoupling agent mCICCP (membrane potential lost) (white) fragment of caspase-9 was detected. As a reference, a clear, rapid processing of caspase-9 in the Rat-1 MycER TM cells is seen after induction of apoptosis and release of cytochrome c by treatment with staurosporine (Figure 7b) , demonstrating that the antibody used (Pharmingen; raised against human caspase-9) recognizes well the proteolytic fragments of rat caspase-9 protein. The cross-reactivity of the caspase-9 antibody with the rat protein was further con®rmed by side by side blotting of a human B-cell lymphoma lysate, in which also the typical generation of the 35 kDa intermediate fragment of caspase-9 after the addition of 1 mM dATP and 0.2 mg cytochrome c in vitro (Li et al., 1997) was observed (data not shown).
p53 in c-Myc-induced apoptosis
Having discovered that MDM2, a negative regulator of p53, and ATM, a p53 kinase (Banin et al., 1998; Canman et al., 1998) , are cleaved, we investigated the behaviour of p53 during c-Myc-induced apoptosis. In our previous studies with Rat-1 MycER TM cells which were not pre-starved for serum, we did not observe any signi®cant changes in the level of p53 protein within 16 h after the induction of c-Myc expression (Kangas et al., 1998) . However, in cells starved ®rst in 0.5% serum for 24 h, the expression of p53 showed an increase at 24 h after the c-Myc activation (Figure 8 ). This was accompanied by an increase in MDM2 and p21, the transcriptional targets of p53 (Figure 8 ). In contrast, the expression of Bax, which is also a transcriptional target of p53, remained unchanged (data not shown).
Discussion
Caspases in c-Myc-induced apoptosis
The mechanisms of c-Myc-induced apoptosis are still unclear. Although it has been suggested that caspases would not be responsible for the apoptotic cell death in apoptosis induced by c-Myc (Green and Reed, 1998; McCarthy et al., 1997; Tsunoda et al., 1999) , we propose the opposite. This conclusion is supported by the following observations. First, the caspase inhibitor Z-VAD is able to inhibit or delay the progression of apoptosis induced by c-Myc (Kagaya et al., 1997; Kangas et al., 1998; McCarthy et al., 1997) . Here, it is important to take into account that a 100% inhibition of the activity of the caspases may be impossible to achieve whereby the caspase cascade may eventually become activated despite the presence of the inhibitor, which complicates the interpretations. Second, caspase-3 has been shown to become cleaved to active subunits early during the c-Myc-induced apoptosis (Kangas et al., 1998) . Third, several of the proteins previously Figure 1 . After harvesting, the cells were gently disrupted in a glass homogenizer and subjected to subcellular fractionation as described in Materials and methods. Proteins (40 mg) from the cytosolic fraction and mitochondrial preparation were separated by SDS ± PAGE (12%), and immunoblotted with anti-cytochrome c antibody. Cytochrome c is indicated by the arrow. The 46 kDa protein cross-reacting with the cytochrome c antibody (Ziv et al., 1997) is shown for the loading control Figure 6 , were resolved on SDS ± PAGE (12%) and subjected to immunoblotting analysis with polyclonal anti-caspase-9 antibody (Pharmingen). Of note, similar results were also obtained in independent experiments using total cellular proteins for the Western blot analysis of caspase-9 (not shown). (b) Rat-1 MycER TM cells were exposed or not to 0.2 mM staurosporine for 5 h, whereafter the cytosolic fractions were prepared and subjected to Western blot analysis of caspase-9 as above. The typical release of cytochrome c following the staurosporine treatment is demonstrated by immunoblotting with the anti-cytochrome c antibody in the bottom panel. The 46 kDa protein unspeci®cally reacting with the anti-cytochrome c antibody is shown for the loading control. In a and b the intact 46 kDa caspase-9 protein (doublet) is shown by the asterisk (*) and the about 17 kDa cleavage product representing the large subunit of caspase-9 is indicated by the arrow demonstrated to be speci®c targets of caspases (and thought to be important for various cellular functions) get proteolytically cleaved during the apoptotic cell death initiated by c-Myc (this study). Fourth, mouse embryo ®broblasts de®cient in caspase-9 are resistant to c-Myc-induced apoptosis (Soengas et al., 1999) .
Proteolytic cleavage of ATM in apoptosis
There is previous evidence that ATM, the protein product of the gene mutated in ataxia telangiectasia, could be associated with the regulation of apoptosis. First, autopsies of AT-homozygote patients reveal extensive apoptosis in dierent tissues, and second, there is increased spontaneous apoptosis in AT-cells in cell culture as compared to their normal counterparts (Meyn, 1995 and references therein) . Also, it has been reported recently that if the expression of ATM is prevented by an anti-sense expression of ATM, the viability of cells decreases following ionizing radiation (Zhang et al., 1998) . Of speci®c interest, in our search for new caspase substrates we identi®ed ATM as a candidate. ATM is a large, multifunctional protein that could regulate apoptosis in multiple ways. However, the carboxyterminal PI-3-kinase domain likely has the most signi®cant activity (Morgan and . Finding that ATM is cleaved when apoptosis occurs, and that ectopic overexpression of full-length ATM protects in part from apoptosis, it seems likely that the proteolytic cleavage of ATM results in loss of the activity of the protein. In support of this, treatment of recombinant ATM with caspases 3 and 7 abrogated its kinase activity toward p53 (data not shown). The ®nding that ATM is cleaved also during the staurosporine-induced apoptosis in Rat-1 and HL-60 cells suggests that ATM may be an important apoptotic target in general. However, a recent contradictory study shows that a subpopulation of neuronal cells lacking functional ATM is more resistant to apoptosis following ionizing irradiation (Herzog et al., 1998) . Presumably, the results may depend on the apoptotic stimulus (signalling pathways) or cell type.
Mitochondria and caspases
Our ®nding that the mitochondrial transmembrane potential is lost during c-Myc-induced apoptosis and that the disruption of DCm is inhibited by Z-VAD-fmk implies that the mitochondria may function in mediating the apoptotic signal in c-Myc-induced cell death or be direct eectors of apoptosis as such. In various other forms of apoptosis, the loss of the mitochondrial transmembrane potential and the formation of permeability transition pores have been suggested to result in a release of mitochondrial proteins into the cytoplasm (e.g. AIF and cytochrome c) (reviewed in Green and Reed, 1998; Kroemer et al., 1997) , although the release of cytochrome c may also occur independently of the loss of the DCm (BossyWetzel et al., 1998). Cytochrome c is then thought to trigger the activation/autocleavage of caspase-9, which in turn activates caspase-3 (Zou et al., 1997) . We found that also in Rat-1 MycER TM ®broblasts cytochrome c becomes translocated from the mitochondria into the cytoplasm relatively early (at 8 ± 16 h) during c-Mycinduced apoptosis. However, the processing of caspase-9 occurred only after 48 h, i.e. considerably later than the activation of caspase-3 (at 8 ± 16 h) (Kangas et al., 1998) . This could be taken as an indication that caspase-9 is not responsible for the processing of caspase-3. However, it is notable that caspase-9 may also be activated, at least in vitro, without proteolytic processing by the cytosolic factors released from mitochondria (Stennicke et al., 1999) . Anyway, our ®nding that the proteolytic processing of caspase-3 is inhibited by the caspase inhibitor Z-VAD in the Rat-1 MycER TM cells (Kangas et al., 1998) indicates that there is some apical caspase to be identi®ed. Whether the same upstream caspase could also be responsible for the Z-VAD sensitive loss of the mitochondrial membrane potential following c-Myc induction remains interesting to be seen. We are currently studying the possible involvement of caspase-8 in the regulation of these processes.
p53 and caspases
The role of p53 in c-Myc-induced apoptosis is a controversial issue (for reviews see Prendergast, 1999; Thompson, 1998) . In the Rat-1 MycER TM cells, we found that the stabilization of p53 occurs signi®cantly later than the activation of caspases (caspase-3). Thus, the accumulation of p53 is unlikely to be an initiating signal for the activation of caspases and the induction of apoptosis by c-Myc. However, p53 might well trigger or potentiate the caspase-9 activity (Soengas et al., 1999) or induce a novel caspase (Pochampally et al., 1999) , and thereby promote the apoptotic cell death in these cells.
Materials and methods
Cell culture
The Rat-1 MycER TM ®broblast cell line expressing a conditionally active c-Myc-oestrogen receptor chimera has been described previously (Littlewood et al., 1995) . The cells were routinely cultured in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 5% foetal calf serum (FCS) and antibiotics. For experiments, the cells were allowed to adhere to culture dishes in normal growth media overnight, washed in serum-free medium, replenished with DMEM with antibiotics and 0.5% FCS and cultured for 24 h. To activate c-Myc and induce apoptosis, 100 nM 4- hydroxytamoxifen (Research Biochemicals International, USA) was added to the media and the cells were harvested at the indicated times. To assess the role of caspases in the various apoptotic processes the cells were treated with cell penetrative inhibitors N-benzyloxycarbonyl-Val-Ala-Aspuoromethyl-ketone (Z-VAD-fmk) and N-benzyloxycarbonyl-Asp-Glu-Val-Asp-¯uoromethyl-ketone (Z-DEVD-fmk) (Enzyme System Products, USA) 2 h prior to and during the induction of apoptosis.
For comparison, the Rat-1 MycER TM cells were also subjected to apoptosis by treatment with staurosporine (Calbiochem; 0.2 mM) in the presence of normal growth medium (DMEM supplemented with 5% FCS) for the indicated times. HL-60 cells were grown in RPMI supplemented with 5% FCS and treated with 1 mM staurosporine to induce apoptosis.
Generation of Rat-1 MycER
TM fibroblasts stably expressing human ATM Rat-1 MycER TM ®broblasts were transfected with 1 mg of the episomal pEBS7-YZ5 expression vector carrying a FLAG epitope-tagged, full-length human ATM cDNA and the hygromycin resistance gene (Ziv et al., 1997) ; kindly provided by Dr Y Shiloh, University of Tel Aviv, Israel) and with the empty vector (pEBS7) by using the FUGENE TM 6 transfection reagent (Boehringer Mannheim). Stable transfectants were selected in the presence of 200 ± 400 mg/ml of hygromycin B for 3 ± 4 weeks. A total pool of the transfectants was used in the experiments.
Western blotting and antibodies
Protein analyses by SDS ± PAGE and immunoblotting were performed as described previously (Kangas et al., 1998) .
The following antibodies were used for immunoblotting: Anti-Rb G3-245, anti-p53 pAb240, and polyclonal anticaspase-9 (Pharmingen, USA); monoclonal anti-gelsolin (Transduction Laboratories, USA); anti-ATM AHP392 (Serotech, UK); anti-SREBP K-10, anti-MDM2 SMP14, anti-p53 N-19, and anti-cPLA2 N-216 (Santa Cruz Biotechnologies, USA); anti-lamin B1 and anti-lamin A+B2 (Zymed Laboratories, USA); polyclonal anti-PKCd (Gibco ± BRL); anti-actin A-2668 and monoclonal anti-FLAG M2 antibody (Sigma Chemicals Co.); polyclonal anti-D4-GD1 ; monoclonal anti-fodrin (NaÈ rvaÈ nen et al., 1987); polyclonal anti-Gas2 (Brancolini et al., 1995) ; anti-PARP C2-10 ( Lamarre et al., 1988) ; polyclonal anti-RFC (Luckow et al., 1994) ; human anti-U1-70 kDa (CasciolaRosen et al., 1995) .
Expression and purification of the recombinant ATM protein from 293 cells
Human embryonic kidney 293-EBNA cells were grown in DMEM and 5% FCS with antibiotics. The cells were transfected overnight with 1 mg of the FLAG-tagged, fulllength human ATM expression vector (Ziv et al., 1997) by using the FUGENE TM 6 reagent. After culturing for 2 days the cells were harvested, lysed in 250 ml of freshly prepared extraction buer (20 mM HEPES, pH 7.5, 50 mM NaF, 450 mM NaCl, 25% glycerol, 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM AEBSF and 10 mg/ml of aprotinin and leupeptin) by freezing and thawing twice, and the lysate was centrifuged at 14 000 g for 7 min at 48C to pellet cell debris (for refs see Ziv et al., 1997) . The supernatant was diluted at a 1 : 3 ratio with 20 mM HEPES, pH 7.5, 0.3% NP-40 and the recombinant ATM protein was anity-puri®ed by incubation of the cell extract with 15 mg of anti-FLAG M2 antibody at 48C overnight (Ziv et al., 1997) . The immunocomplexes were harvested by using agarose-beads with covalently conjugated goat anti-mouse IgG (40 ml) and washed three times (with the extraction buer diluted at a 1 : 3 ratio with 20 mM HEPES, pH 7.5, 0.3% NP-40).
In vitro ATM cleavage by caspases
Puri®ed recombinant human ATM protein (isolated from the 293-EBNA cells as described above) was incubated with 0.5 mg of the dierent recombinant active caspases (from Pharmingen) in a 20 ml reaction mixture containing 25 mM HEPES, pH 7.5, 100 mM NaCl, 1 mM EDTA, 5 mM DTT and 0.1% CHAPS at 378C for 20 min. The reactions were stopped by adding Laemmli sample buer. The samples were resolved on SDS ± PAGE followed by immunoblotting with the anti-ATM AHP392 antibody.
Measurement of mitochondrial transmembrane potential
Cells were harvested by centrifugation and washed twice with PBS, incubated at 378C for 15 min in the presence of 40 nM 3,3'-dihexyloxacarbocyanine iodide [DioC 6 (3)] (Molecular Probes, USA) and washed (Petit et al., 1990; Zamzami et al., 1995) . As a control, the cells were pre-treated with 100 mM carbonyl cyanide m-chlorophenylhydrazone (mCICCP, Sigma Chemical Co.), an uncoupling agent, for 45 min. The FACS analysis was performed with 488 nm excitation and 525 nm emission.
Subcellular fractionation for analysis of cytochrome c release from mitochondria
Rat-1 MycER TM cells cultured with or without OHT were collected by centrifugation and suspended in 0.25 ml of the extraction buer (250 mM sucrose, 10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl 2 , 0.5 mM EGTA, 1 mM dithiothreitol, 1 mM AEBSF and 10 mg/ml each of the protease inhibitors aprotinin, leupeptin and pepstatin). The cells were disrupted by homogenization with 20 strokes in a Kontes glass homogenizer (pestle number 21) on ice. The cell lysate was centrifuged at 700 g for 10 min at 48C to remove nuclei and cell debris, and the resulting supernatant was further centrifuged at 10 000 g for 15 min at 48C. The supernatant (crude cytosolic fraction) was collected, mixed 5 : 1 with ®vefold Laemmli buer and the pellet containing mitochondria was resuspended in 50 ml of Laemmli sample buer. The concentration of proteins was determined by the BCA protein assay reagent (Pierce), the proteins separated by SDS ± PAGE, and the content of cytochrome c analysed by immunoblotting.
Note added in proof After submission of this work, Smith et al. (1999) have also reported that ATM is a substrate for caspase-3.
